We are live on ! Find out more
ELDN icon

Eledon Pharmaceuticals
ELDN

27 hedge funds and large institutions have $76.8M invested in Eledon Pharmaceuticals in 2014 Q3 according to their latest regulatory filings, with 27 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
27
Holders Change
+27
Holders Change %
–
% of All Funds
0.78%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
27
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
NHAS
Novo Holdings A/S
Denmark
+$18.9M
2
Fidelity Investments
Fidelity Investments
Massachusetts
+$10.1M
3
TCP
Tourbillon Capital Partners
New York
+$8.42M
4
RG
Redmile Group
California
+$7.27M
5
Franklin Resources
Franklin Resources
California
+$7.02M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
NHAS
1
Novo Holdings A/S
Denmark
$15.5M +$18.9M +6,636 New
Fidelity Investments
2
Fidelity Investments
Massachusetts
$8.71M +$10.1M +3,549 New
TCP
3
Tourbillon Capital Partners
New York
$7.27M +$8.42M +2,963 New
RG
4
Redmile Group
California
$6.27M +$7.27M +2,558 New
Franklin Resources
5
Franklin Resources
California
$6.06M +$7.02M +2,469 New
DCM
6
Discovery Capital Management
Connecticut
$4.6M +$5.33M +1,877 New
Alyeska Investment Group
7
Alyeska Investment Group
Illinois
$4.13M +$4.79M +1,685 New
Ameriprise
8
Ameriprise
Minnesota
$3.77M +$4.36M +1,535 New
SFM
9
Sphera Funds Management
Israel
$3.48M +$4.04M +1,420 New
KCM
10
Kingdon Capital Management
New York
$3.1M +$3.6M +1,265 New
JP Morgan Chase
11
JP Morgan Chase
New York
$3.01M +$3.49M +1,227 New
PA
12
Perceptive Advisors
New York
$2.73M +$3.16M +1,111 New
Jennison Associates
13
Jennison Associates
New York
$2.38M +$2.76M +970 New
Morgan Stanley
14
Morgan Stanley
New York
$2.36M +$2.74M +963 New
PI
15
Putnam Investments
Massachusetts
$1.02M +$1.19M +417 New
Millennium Management
16
Millennium Management
New York
$802K +$929K +327 New
Deutsche Bank
17
Deutsche Bank
Germany
$738K +$856K +301 New
DCM
18
Destrier Capital Management
New York
$254K +$296K +104 New
CSS
19
Cubist Systematic Strategies
Connecticut
$252K +$293K +103 New
SIM
20
Spark Investment Management
New York
$155K +$182K +64 New
Bank of Montreal
21
Bank of Montreal
Ontario, Canada
$121K +$139K +49 New
Creative Planning
22
Creative Planning
Kansas
$50K +$56.8K +20 New
U
23
UBS
Switzerland
$16K +$19.9K +7 New
SFPIA
24
Stevens First Principles Investment Advisors
California
$12K +$14.2K +5 New
Citigroup
25
Citigroup
New York
$11K +$11.4K +4 New
1
2

ELDN Hedge Fund Activity: Q3 2014 in Review

27 of the 3,448 institutional investors tracked by Wall St. Rank reported a position in Eledon Pharmaceuticals (ELDN) for Q3 2014, worth a combined $76.8M.

Buyers outnumbered sellers: 27 funds opened new ELDN positions and 0 closed out — a net gain of 27 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was Novo Holdings A/S, opening a new position worth an estimated $18.9M.

  • 27 institutional investors held Eledon Pharmaceuticals (ELDN) as of Q3 2014, up from 0 in Q2 2014.
  • Funds reported $76.8M of Eledon Pharmaceuticals stock for Q3 2014.
  • 27 funds opened new Eledon Pharmaceuticals positions in Q3 2014 and 0 closed out, a net change of +27 holders.
  • The largest Eledon Pharmaceuticals buyer in Q3 2014 was Novo Holdings A/S, an estimated $18.9M added.

Based on aggregated 13F filings for Q3 2014.